| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |